Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples

Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples

<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causing agent for COVID-19, has led to over 7 million deaths since it was first detected in Wuhan, China in December 2019. Antibodies induced by both vaccination and infection are crucial for the immune protection ag...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteur:	Liu, C
Andere auteurs:	Screaton, GR
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	2024
Onderwerpen:	Immunology

Gelijkaardige items

SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract
door: Alba Escalera, et al.
Gepubliceerd in: (2024-03-01)

Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
door: Xiao-Lin Jiang, et al.
Gepubliceerd in: (2024-07-01)

Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
door: Cyril Planchais, et al.
Gepubliceerd in: (2024-07-01)

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
door: Jeewandara, C, et al.
Gepubliceerd in: (2021)

Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
door: Jay, C
Gepubliceerd in: (2023)

Nonhuman primate antigenic cartography of SARS-CoV-2
door: Annika Rössler, et al.
Gepubliceerd in: (2025-01-01)

Studies on immunoreceptor activation and SARS-CoV-2 RBD/ACE2 interactions
door: Barton, MI
Gepubliceerd in: (2022)

Anti-SARS-CoV-2 antibodies in a nasal spray efficiently block viral transmission between ferrets
door: Kiira Gildemann, et al.
Gepubliceerd in: (2024-07-01)

SARS-CoV-2 produces a microRNA CoV2-miR-O8 in patients with COVID-19 infection
door: Elise J. Tucker, et al.
Gepubliceerd in: (2024-01-01)

Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies
door: Youngchang Kim, et al.
Gepubliceerd in: (2024-02-01)

Development of human monoclonal antibodies against SARS-CoV-2
door: Wong, Joel Xu En
Gepubliceerd in: (2021)

SARS-CoV-2 infection elucidates features of pregnancy-specific immunity
door: Dong Sun Oh, et al.
Gepubliceerd in: (2024-11-01)

Multivariate analyses and machine learning link sex and age with antibody responses to SARS-CoV-2 and vaccination
door: Miroslava Cuperlovic-Culf, et al.
Gepubliceerd in: (2024-08-01)

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
door: Tetsuya Inoue, et al.
Gepubliceerd in: (2024-04-01)

Increasing Sporadic Covid-19 Cases:Should We Heed Airborne Transmission Of SARS-CoV-2?
door: Ahmad Mahfuz, Gazali
Gepubliceerd in: (2021)

An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
door: Banghui Liu, et al.
Gepubliceerd in: (2024-06-01)

Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control
door: Liu, G
Gepubliceerd in: (2023)

Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2
door: Martina Severa, et al.
Gepubliceerd in: (2024-05-01)

SARS-CoV-2 vaccine development and challenges
door: Duan Fugang, et al.
Gepubliceerd in: (2021-03-01)

Elucidating factors of heterogeneous immune response to SARS-CoV-2 and human immunodeficiency virus
door: Lim, N
Gepubliceerd in: (2024)

Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1
door: Zhou Tong, et al.
Gepubliceerd in: (2024-06-01)

SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity
door: Elizabeth J. Martinez, et al.
Gepubliceerd in: (2024-10-01)

Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections
door: Sung-Gwon Lee, et al.
Gepubliceerd in: (2024-03-01)

Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
door: Cara W. Chao, et al.
Gepubliceerd in: (2024-12-01)

SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
door: Sarah E. Cummings, et al.
Gepubliceerd in: (2024-01-01)

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
door: Carter, Brandon, et al.
Gepubliceerd in: (2023)

tANCHOR-cell-based assay for monitoring of SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domains
door: Daniel Ivanusic, et al.
Gepubliceerd in: (2024-03-01)

Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1
door: Alexander Muik, et al.
Gepubliceerd in: (2024-08-01)

Convergence of SARS-CoV-2 spike antibody levels to a population immune setpointResearch in context
door: Eric J. Nilles, et al.
Gepubliceerd in: (2024-10-01)

Characterising the T cell responses to SARS-CoV-2 including variants of concern induced by natural infection and vaccines
door: Adele, S
Gepubliceerd in: (2024)

Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters
door: Rajesh Rajaiah, et al.
Gepubliceerd in: (2024-08-01)

Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
door: Lu Zhang, et al.
Gepubliceerd in: (2024-06-01)

Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection
door: Mohamed I.M. Ahmed, et al.
Gepubliceerd in: (2024-06-01)

Immune imprinting of SARS-CoV-2 responses: changing first immune impressions
door: J. Torresi, et al.
Gepubliceerd in: (2024-04-01)

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine
door: Masayuki Aboshi, et al.
Gepubliceerd in: (2024-02-01)

A systems biology approach to define SARS-CoV-2 correlates of protection in non-human primates
door: Brady, C
Gepubliceerd in: (2024)

The alarmin IL-33 exacerbates pulmonary inflammation and immune dysfunction in SARS-CoV-2 infection
door: Hui Wang, et al.
Gepubliceerd in: (2024-06-01)

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
door: Willett, BJ, et al.
Gepubliceerd in: (2022)

SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
door: Hirsch, C, et al.
Gepubliceerd in: (2021)

SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
door: Kreuzberger, N, et al.
Gepubliceerd in: (2021)